Novelrad

Company Overview

Snapshot

Founded in January 2019 by Netanel Sharabani and Ori Goldor, Novelrad operates with 1–10 employees. The company has raised $8.25 million across three funding rounds. In February 2025, Novelrad was featured for its micro-suturing solutions for transcatheter vascular and cardiac repair.

Business overview

Novelrad is a clinical-stage medical device company specializing in minimally-invasive cardiovascular interventions. The company develops a proprietary transcatheter micro-suturing platform designed to bring surgical-quality suturing capabilities to large-bore vascular and structural heart procedures. Its technology enables the deployment of precise multi-point sutures through a catheter-based approach, aiming to enhance safety, reliability, and procedural efficiency. Novelrad operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In February 2025, Novelrad was highlighted for its micro-suturing solutions for transcatheter vascular and cardiac repair. This signals the company's continued progress in developing and validating its core technology, indicating potential for significant advancements in cardiovascular treatment and a strong market position within the medical device industry.

Company Intelligence Q&A

What is Novelrad's core technology?

Novelrad develops a proprietary transcatheter micro-suturing platform designed to bring surgical-quality suturing capabilities into minimally invasive cardiovascular interventions, enabling precise multi-point sutures through a catheter-based approach.

When was Novelrad founded and by whom?

Novelrad was founded in January 2019 by Netanel Sharabani and Ori Goldor.

What was a key development for Novelrad in February 2025?

In February 2025, Novelrad was featured for its micro-suturing solutions for transcatheter vascular and cardiac repair, highlighting its advancements in medical device technology.

What is the total capital raised by Novelrad?

Novelrad has raised a total of $8.25 million across three funding rounds.

What type of grant did Novelrad secure in May 2023?

In May 2023, Novelrad secured a non-dilutive grant from the EIC Accelerator. This grant was part of a funding round that contributed to the over $7 million raised by the company.